1. Home
  2. HUSA vs UBX Comparison

HUSA vs UBX Comparison

Compare HUSA & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUSA
  • UBX
  • Stock Information
  • Founded
  • HUSA N/A
  • UBX 2009
  • Country
  • HUSA United States
  • UBX United States
  • Employees
  • HUSA N/A
  • UBX N/A
  • Industry
  • HUSA Oil & Gas Production
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUSA Energy
  • UBX Health Care
  • Exchange
  • HUSA Nasdaq
  • UBX Nasdaq
  • Market Cap
  • HUSA 16.9M
  • UBX 16.5M
  • IPO Year
  • HUSA N/A
  • UBX 2018
  • Fundamental
  • Price
  • HUSA $1.67
  • UBX $1.73
  • Analyst Decision
  • HUSA
  • UBX Strong Buy
  • Analyst Count
  • HUSA 0
  • UBX 2
  • Target Price
  • HUSA N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • HUSA 501.1K
  • UBX 303.9K
  • Earning Date
  • HUSA 11-14-2024
  • UBX 11-04-2024
  • Dividend Yield
  • HUSA N/A
  • UBX N/A
  • EPS Growth
  • HUSA N/A
  • UBX N/A
  • EPS
  • HUSA N/A
  • UBX N/A
  • Revenue
  • HUSA $640,348.00
  • UBX N/A
  • Revenue This Year
  • HUSA N/A
  • UBX N/A
  • Revenue Next Year
  • HUSA N/A
  • UBX $33.62
  • P/E Ratio
  • HUSA N/A
  • UBX N/A
  • Revenue Growth
  • HUSA N/A
  • UBX N/A
  • 52 Week Low
  • HUSA $0.96
  • UBX $0.94
  • 52 Week High
  • HUSA $2.57
  • UBX $2.02
  • Technical
  • Relative Strength Index (RSI)
  • HUSA 58.68
  • UBX 63.32
  • Support Level
  • HUSA $1.56
  • UBX $1.56
  • Resistance Level
  • HUSA $2.06
  • UBX $1.85
  • Average True Range (ATR)
  • HUSA 0.17
  • UBX 0.22
  • MACD
  • HUSA 0.04
  • UBX 0.05
  • Stochastic Oscillator
  • HUSA 51.25
  • UBX 75.96

About HUSA Houston American Energy Corporation

Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Texas and Louisiana, and the South American country of Colombia. The company's exploration and development projects are focused on existing property interests, and future acquisition of additional property interests, in the Texas Permian Basin, the onshore Texas and Louisiana Gulf Coast region, and the South American country of Colombia. The Company majorly has operations in two geographical areas, the United States and Colombia.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: